Company Filing History:
Years Active: 2015-2021
Title: Jan-Olof G Karlsson: Innovator in Pharmaceutical Chemistry
Introduction
Jan-Olof G Karlsson is a notable inventor based in Trondheim, Norway. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at alleviating the side effects of chemotherapy. With a total of 5 patents to his name, Karlsson's work is recognized for its innovative approach to treating chemotherapy-induced conditions.
Latest Patents
One of Karlsson's latest patents focuses on the use of non-transition metal coordinated dipyridoxyl compounds to prevent and treat chemotherapy-induced peripheral sensory neuropathy (PSN). This patent discloses a platinum ion chelating dipyridoxyl compound, which can be administered separately from chemotherapy drugs, such as oxaliplatin. The innovation addresses the drawbacks of previous manganese complexed compounds, eliminating the risk of accumulated manganese neurotoxicity. Another significant patent involves a pharmaceutical composition that combines a manganese complex with a non-manganese complex compound, providing a dual approach to treating pathological conditions caused by oxygen-derived free radicals.
Career Highlights
Throughout his career, Jan-Olof G Karlsson has worked with various companies, including Pledpharma AB and Karlsson-Tuner Invest AS. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.
Collaborations
Karlsson has collaborated with notable professionals in his field, including Rolf Andersson and Karl Reineke. These partnerships have further enhanced his research and development efforts.
Conclusion
Jan-Olof G Karlsson is a distinguished inventor whose work in pharmaceutical chemistry has the potential to significantly improve the quality of life for patients undergoing chemotherapy. His innovative patents reflect a commitment to addressing critical health challenges through scientific advancement.